|
- Pneumococcal Vaccine Recommendations | Pneumococcal | CDC
Based on shared clinical decision-making, adults 65 years or older have the option to get PCV20 or PCV21, or to not get additional pneumococcal vaccines They can get PCV20 or PCV21 if they have received both
- Comparing Pneumococcal Vaccines and CDC Recommendations for Adults
Three conjugate vaccines—PCV-15, PCV-20, and PCV-21—begin with "PCV" (pneumococcal conjugate vaccine), while the polysaccharide vaccine is PPSV-23 (23-valent pneumococcal polysaccharide vaccine)
- Pneumococcal vaccine side- by-side comparison
criteria for superiority compared with PCV13 PCV15 and PCV13, each followed by PPSV23 were evaluated in healthy adults 50 years of age and older (PNEU-PATH) and in adults 18 to 49 years of ag
- New Pneumococcal Vaccine Recommendations: What to Know
In most US geographic areas, PCV 21 is expected to cover more circulating pneumococcal strains than PCV 20 or PCV 15 Of note, this is not true everywhere, specifically in geographic
- Expanded Recommendations for Use of Pneumococcal Conjugate Vaccines . . .
The ACIP Pneumococcal Vaccines Work Group employed the Evidence to Recommendations framework to guide its deliberations on expanding the age-based PCV recommendation to include adults aged 50-64 years On October 23, 2024, ACIP recommended a single dose of PCV for all PCV-naïve adults aged ≥50 years
- Pneumococcal Vaccines for Seniors - Family Doctor
PCV15 or PCV20 is recommended for adults 65 years or older and adults 19 through 64 years old with certain medical conditions or risk factors PCV15 and PCV20: What’s the Difference? This conjugate vaccine protects against 15 different types of bacteria that cause pneumococcal disease
- Cost-effectiveness of 15-valent or 20-valent pneumococcal conjugate . . .
Age-based use of either PCV20 alone or PCV15 in series with PPSV23 at age 65 years were both shown to be cost-saving (improved health outcomes and saved costs)
- Updated Recommendations for Pneumococcal Vaccination
For adults aged 50 years and older who have never received a pneumococcal vaccine, the ACIP recommends either PCV20 or PCV21 as a one-time dose or PCV15 followed by one dose of 23-valent pneumococcal polysaccharide vaccine (PPSV23) 1 year later
|
|
|